Official ESCRS | European Society of Cataract & Refractive Surgeons
Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





Artificial iris lens diaphragm in reconstructive surgery for aniridia and aphakia

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Cataract Surgery Special Cases

Session Date/Time: Sunday 06/09/2015 | 10:30-12:30

Paper Time: 11:26

Venue: Room 10

First Author: : K.Okasha PALESTINE

Co Author(s): :                        

Abstract Details

Purpose:

To determine the efficacy and safety of surgical implantation of artificial iris lens diaphragm in patients with anatomic or functional iris deficiencies associated with aphakia or cataract.

Setting:

International Eye Center. Gaza. Palestine

Methods:

4 eyes of 3 patients with combined iris and lens pathology of traumatic or congenital etiology were identified for an interventional noncomparative case series. The newly proposed model of an elastic iris–lens diaphragm with colored haptic and additional support elements was implanted using various fixation approaches.

Results:

All patient experienced improvement in corrected visual acuities. All patients were satisfied with the cosmetic results of the surgery and reported a decrease in glare and photophobia. No intraoperative complications were noted. Postoperatively 1 case of hyphema was observed. In 1 eye, there was persistent intraocular pressure rise. No iris lens diaphragm decentration was seen during the follow-up period.

Conclusions:

Artificial iris lens diaphragm implantation effectively improved postoperative outcomes by correcting aphakia, reducing glare disability, and addressing cosmetic issues faced by iris-deficient associated with aphakic or cataract patients. Although the iris lens diaphragm appears to be safe, long-term results must be clarified in studies with longer follow-up and a larger patient population.

Financial Interest:

NONE

Back to previous